Nifedipine Administration for Threatened Preterm Labor

Initial Administration and Monitoring

• Nifedipine should be administered orally, not sublingually, as sublingual administration increases the risk of sudden hypotension 1
• Maternal blood pressure should be monitored closely, especially during the first hour of treatment, to minimize the risk of hypotension 1
• The goal of tocolysis is to delay delivery for at least 48 hours to allow for corticosteroid administration for fetal lung maturity 1

Precautions and Contraindications

• Nifedipine should be used with caution when combined with magnesium sulfate due to the risk of precipitous blood pressure drop 1, 2
• Close monitoring is essential when using nifedipine in combination with magnesium sulfate 2
• Nifedipine is not FDA-approved specifically for preterm labor management but is used off-label for this indication 1

Side Effects and Alternative Approaches

• Common side effects of nifedipine include headache, flushing, and dizziness 1
• If immediate-release nifedipine is not available and intravenous access has not been established, 200 mg of labetalol or 1.0-1.5 g of methyldopa can be administered orally 2, 3
• For hypertensive emergencies in pregnancy, a different dosing regimen is used (10-20 mg short-acting nifedipine with possible repeat in 30 minutes) 3, 4

Important Clinical Considerations

• Short-acting nifedipine should be avoided for maintenance therapy in pregnancy as it can cause uncontrolled hypotension 5